Cerity Partners’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472K | Sell |
22,834
-18,070
| -44% | -$373K | ﹤0.01% | 1896 |
|
|
2025
Q1 | $801K | Sell |
40,904
-10,360
| -20% | -$203K | ﹤0.01% | 1523 |
|
|
2024
Q4 | $1.21M | Buy |
51,264
+3,261
| +7% | +$76.8K | ﹤0.01% | 1329 |
|
|
2024
Q3 | $1.17M | Buy |
48,003
+6,103
| +15% | +$149K | ﹤0.01% | 1327 |
|
|
2024
Q2 | $1.05M | Sell |
41,900
-7,244
| -15% | -$182K | ﹤0.01% | 1203 |
|
|
2024
Q1 | $1.47M | Sell |
49,144
-5,909
| -11% | -$177K | ﹤0.01% | 1105 |
|
|
2023
Q4 | $1.75M | Buy |
55,053
+42,661
| +344% | +$1.36M | 0.01% | 797 |
|
|
2023
Q3 | $437K | Sell |
12,392
-52,072
| -81% | -$1.84M | ﹤0.01% | 1023 |
|
|
2023
Q2 | $2.45M | Buy |
64,464
+28
| +0% | +$1.06K | 0.01% | 669 |
|
|
2023
Q1 | $2.43M | Sell |
64,436
-2,778
| -4% | -$105K | 0.01% | 662 |
|
|
2022
Q4 | $2.85M | Buy |
67,214
+1,072
| +2% | +$45.4K | 0.02% | 467 |
|
|
2022
Q3 | $2.13M | Buy |
66,142
+5,182
| +9% | +$166K | 0.03% | 363 |
|
|
2022
Q2 | $1.98M | Buy |
60,960
+5,230
| +9% | +$170K | 0.02% | 404 |
|
|
2022
Q1 | $2.02M | Sell |
55,730
-11,319
| -17% | -$410K | 0.03% | 328 |
|
|
2021
Q4 | $2.65M | Buy |
67,049
+7,545
| +13% | +$299K | 0.04% | 278 |
|
|
2021
Q3 | $2.6M | Sell |
59,504
-167
| -0.3% | -$7.3K | 0.06% | 228 |
|
|
2021
Q2 | $2.44M | Buy |
59,671
+66
| +0.1% | +$2.69K | 0.05% | 237 |
|
|
2021
Q1 | $1.96M | Sell |
59,605
-2,691
| -4% | -$88.4K | 0.05% | 259 |
|
|
2020
Q4 | $2.53M | Buy |
62,296
+7,439
| +14% | +$302K | 0.08% | 183 |
|
|
2020
Q3 | $2.01M | Buy |
+54,857
| New | +$2.01M | 0.08% | 168 |
|
|
2019
Q4 | – | Sell |
-12,340
| Closed | -$250K | – | 548 |
|
|
2019
Q3 | $250K | Buy |
+12,340
| New | +$250K | 0.01% | 422 |
|